We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.8%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$83B
AUM Growth
+$4.08B
(+5.2%)
Cap. Flow
-$2.07B
Cap. Flow
% of AUM
-2.5%
Top 10 Holdings %
Top 10 Hldgs %
13.18%
Holding
730
New
59
Increased
161
Reduced
398
Closed
45
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Keurig Dr Pepper
KDP
|
+$550M |
| 2 |
Fidelity National Information Services
FIS
|
+$353M |
| 3 |
Global Payments
GPN
|
+$263M |
| 4 |
CVS Health
CVS
|
+$175M |
| 5 |
Devon Energy
DVN
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$433M |
| 2 |
Lowe's Companies
LOW
|
+$277M |
| 3 |
Oracle
ORCL
|
+$226M |
| 4 |
Progressive
PGR
|
+$220M |
| 5 |
Las Vegas Sands
LVS
|
+$167M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.96% |
| 2 | Healthcare | 15.3% |
| 3 | Industrials | 15.12% |
| 4 | Technology | 14.91% |
| 5 | Consumer Discretionary | 11.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Scorpio Tankers
STNG
$3.94B
| $560K | ﹤0.01% |
43,685
-11,278
| -21% | -$174K |
|
602
Constellium
CSTM
$3.98B
| $549K | ﹤0.01% |
30,679
-6,688
| -18% | -$123K |
|
|
DCH
603
Dauch Corp
DCH
$1.32B
| $548K | ﹤0.01% |
58,704
+6,248
| +12% | +$59.8K |
|
604
Gibraltar Industries
ROCK
$1.4B
| $542K | ﹤0.01% |
8,127
-1,115
| -12% | -$79.6K |
|
605
Civista Bancshares
CIVB
$610M
| $537K | ﹤0.01% |
21,994
| – | – |
|
|
IIN
606
DELISTED
IntriCon Corporation
IIN
| $537K | ﹤0.01% |
33,219
+8,846
| +36% | +$152K |
|
607
Chemours
CC
$2.55B
| $534K | ﹤0.01% |
15,899
-5,146
| -24% | -$160K |
|
|
608
Lowe's Companies
LOW
$122B
| $532K | ﹤0.01% |
2,058
-1,163,411
| -100% | -$277M |
|
609
Graham Corp
GHM
$1.18B
| $531K | ﹤0.01% |
42,702
| – | – |
|
610
Chord Energy
CHRD
$7.25B
| $515K | ﹤0.01% |
4,090
-7,215
| -64% | -$857K |
|
611
ATI
ATI
$25.5B
| $513K | ﹤0.01% |
+32,207
| New | +$517K |
|
612
Baidu
BIDU
$35.7B
| $505K | ﹤0.01% |
3,392
-9,520
| -74% | -$1.49M |
|
613
Natural Gas Services Group
NGS
$457M
| $505K | ﹤0.01% |
48,238
| – | – |
|
|
BECN
614
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $500K | ﹤0.01% |
8,723
| – | – |
|
|
IMBI
615
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
| $495K | ﹤0.01% |
82,566
+19,314
| +31% | +$118K |
|
616
Marten Transport
MRTN
$1.26B
| $489K | ﹤0.01% |
28,504
-23,211
| -45% | -$384K |
|
617
SelectQuote
SLQT
$131M
| $472K | ﹤0.01% |
+52,121
| New | +$571K |
|
618
Comcast
CMCSA
$85.8B
| $471K | ﹤0.01% |
9,364
| – | – |
|
619
Cadre Holdings
CDRE
$1.45B
| $455K | ﹤0.01% |
+17,904
| New | +$363K |
|
|
USAP
620
DELISTED
Universal Stainless & Alloy
USAP
| $445K | ﹤0.01% |
56,359
| – | – |
|
621
iShares Russell Mid-Cap Value ETF
IWS
$15.8B
| $443K | ﹤0.01% |
+3,621
| New | +$432K |
|
|
SCTL
622
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $440K | ﹤0.01% |
257,090
+63,146
| +33% | +$108K |
|
623
Quantum Corp
QMCO
$438M
| $418K | ﹤0.01% |
3,788
-592
| -14% | -$67.5K |
|
|
BDSI
624
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $398K | ﹤0.01% |
+124,809
| New | +$420K |
|
|
ONTF
625
DELISTED
ON24
ONTF
| $379K | ﹤0.01% |
+21,828
| New | +$389K |
|
Similar funds
Boston Partners's Q4 2021 Portfolio in Review
As of Q4 2021, Boston Partners held 730 positions worth $83B, up 5.2% from $78.9B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Boston Partners's Q4 2021 filing shows 59 new, 161 increased, 398 reduced and 45 closed positions. Its largest new stake was Keurig Dr Pepper: 15,605,496 shares worth $575M. The largest sale was Pfizer, an estimated $433M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 22% a quarter earlier, followed by Healthcare and Industrials.
- Boston Partners's largest Q4 2021 buy was Keurig Dr Pepper: 15,605,496 shares worth $575M.
- Boston Partners added most to Fidelity National Information Services in Q4 2021, an estimated $353M increase.
- Boston Partners's biggest Q4 2021 reduction was Pfizer, cutting an estimated $433M.
- Boston Partners fully exited CyrusOne Inc Common Stock in Q4 2021, selling an estimated $137M.
- Boston Partners's ten largest holdings make up 13% of its $83B portfolio in Q4 2021.
- Boston Partners opened 59 new positions and closed 45 in Q4 2021.
- Boston Partners's portfolio value rose 5.2% quarter-over-quarter to $83B.
Based on Boston Partners's 13F filing for Q4 2021, filed 4 Feb 2022.